Alcohol Clin Exp Res. 2022 Mar 7. doi: 10.1111/acer.14801. Online ahead of print.

ABSTRACT

BACKGROUND: Heavy episodic drinking (HED) is a risk factor for opioid-related overdose and negatively impacts HIV disease progression. Among a national cohort of patients with HIV (PWH), we examined sociodemographic and clinical correlates of concomitant HED and self-reported opioid use.

METHODS: We used data collected from 2002 through 2018 from the Veterans Aging Cohort Study, a prospective cohort including PWH in care at eight US Veterans Health Administration sites. HED was defined as consuming six or more drinks at least once in the year prior to survey collection. We examined the relationship between HED and self-reported opioid use and created a 4-level composite variable of HED and opioid use. We used multinomial logistic regression to estimate odds of reporting concomitant HED and self-reported opioid use.

RESULTS: Among 3,702 PWH, 1,458 (39.4%) reported HED during the study period and 350 (9.5%) reported opioid use. In the multinomial model, compared to reporting neither HED or opioid use, lifetime housing instability (adjusted odds ratio [aOR] 1.54, 95% confidence interval [CI] 1.01-2.35), VACS Index 2.0 (a measure of disease severity) (aOR 1.14, 95% CI 1.02-1.28), depressive symptoms (aOR 2.27, 95% CI 1.42-3.62), past-year cigarette smoking (aOR 3.06, 95% CI 1.53-6.14), cannabis use (aOR 1.69, 95% CI 1.09-2.62), and cocaine/stimulant use (aOR 11.54, 95% CI 7.40-17.99) were independently associated with greater odds of concomitant HED and self-reported opioid use. Compared to having attended no college, having some college or more (aOR 0.39, 95% CI 0.26-0.59) was associated with lower odds of concomitant HED and self-reported opioid use.

CONCLUSIONS: Among PWH, concomitant HED and self-reported opioid use are more common among individuals with depressive symptoms and substance use, structural vulnerabilities, and greater illness severity. Efforts to minimize opioid-related risk should address high-risk drinking as a modifiable risk factor for harm among these groups.

PMID:35257397 | DOI:10.1111/acer.14801


Source: ncbi 2

Partage le savoir
Categories: Medical

error: Content is protected !!